⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
JNJ News
Johnson & Johnson
RYBREVANT® (amivantamab-vmjw) longer-term results show promising and durable responses in difficult-to-treat colorectal cancer
prnewswire.com
JNJ
Rejuvacare Ozempatch Ingredients Investigated: 2026 Consumer Analysis Examines Herbal Patch Formulation Disclosures
globenewswire.com
JNJ
LLY
Muscle Relaxant Drugs Market is expected to generate a revenue of USD 6.59 Billion by 2031, Globally, at 5.4% CAGR: Verified Market Research®
globenewswire.com
JNJ
ABBV
Brado and Santé Ventures Partner to Transform Patient Navigation and Engagement
prnewswire.com
BMED
JNJ
BSX
BDX
IBM
Johnson & Johnson Reaches Agreement with U.S. Government to Improve Access to Medicines and Lower Costs for Millions of Americans; Delivers on U.S. Manufacturing and Innovation Investments
businesswire.com
JNJ
GenNx360 Capital Partners Portfolio Company Nutra-Med Packaging Appoints Hany Salama as Chief Executive Officer
businesswire.com
JNJ
MRK
MCK
Global Disposable Endoscopes Market to Accelerate at a CAGR of ~10% by 2032 as Healthcare Shifts Toward Infection-Free Diagnostic Solutions | DelveInsight
globenewswire.com
BSX
SYK
JNJ
WORLDLINE : EGM results - Press release
globenewswire.com
JPM
BAC
WFC
MS
GS
AXP
PYPL
V
MA
CMCSA
T
VZ
IBM
ORCL
SAP
ACN
ADP
PAYX
FIS
FDS
EVO
PSFE
LCID
RIVN
NIO
XPEV
TSLA
GM
F
STLA
CRDO
ADBE
GOOG
AMZN
META
NVDA
INTC
AMD
QCOM
CRM
NFLX
DIS
CMG
MCD
SBUX
PEP
KO
PG
JNJ
PFE
MRK
ABBV
AMGN
GILD
BMY
LLY
UNH
CVS
XOM
CVX
SHEL
BABA
JD
PDD
NTES
BIDU
AMTD
CPT
CA
BP
Hip Replacement Implants Market is expected to generate a revenue of USD 8.44 Billion by 2032, Globally, at 3.94% CAGR: Verified Market Research®
globenewswire.com
JNJ
WMT
COR
ZTR
SN
Johnson & Johnson celebrates innovation in cancer research with 2025 Dr. Paul Janssen Award
prnewswire.com
JNJ